HybriCell is a therapeutic vaccine developed by Brazilian immunologist Jose Alexandre Barbuto. The treatment, which inhibits the division of cancer cells, is aimed at patients in later stages of kidney cancer or melanoma.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.